Matthew Link

Exec. VP U.S. Sales, NuVasive.

Companies

FibroBiologics, Inc.Board member Feb 13, 2024 to now¹
Sight Sciences, Inc.Chief Commercial Officer Sep 12, 2023 to now²
NuVasivePresident Feb 3, 2015 to Jun 10, 2020³
NuVasiveExec. VP U.S. Sales Jan 4, 2013 to Feb 5, 2018⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Sight Sciences, Inc. SGHT832,293 shares⁵$7.3M at $8.76Jul 2, 2025
FibroBiologics, Inc. FBLG7,500 shares⁶$7.3K at $0.97Feb 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 2, 2025Sold 4,889 shares at $4.10 of Sight Sciences, Inc.⁵
May 16, 2025Granted 6,631 shares at $3.02 of Sight Sciences, Inc.⁷
Apr 2, 2025Sold 5,042 shares at $2.31 of Sight Sciences, Inc.⁸
Mar 11, 2025Granted 172,043 shares of Sight Sciences, Inc.⁹
Oct 21, 2024Sold 21,831 shares at $5.61 of Sight Sciences, Inc.¹⁰
Oct 18, 2024Sold 20,487 shares at $5.98 of Sight Sciences, Inc.¹⁰
Oct 17, 2024Sold 20,970 shares at $5.84 of Sight Sciences, Inc.¹¹
Oct 16, 2024Sold 20,734 shares at $5.91 of Sight Sciences, Inc.¹¹
Nov 14, 2023Granted 747,572 shares of Sight Sciences, Inc.¹²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFibroBiologics, Inc., Board member
2
SEC EDGARSight Sciences, Inc., Chief Commercial Officer
3
SEC EDGARNuVasive, President
4
SEC EDGARNuVasive, Exec. VP U.S. Sales
5
SEC EDGARSight Sciences, Inc. shares after the filing of Jul 2, 2025
6
SEC EDGARFibroBiologics, Inc. shares after the filing of Feb 13, 2024
7
SEC EDGARForm 4 filed May 21, 2025
8
SEC EDGARForm 4 filed Apr 3, 2025
9
SEC EDGARForm 4 filed Mar 13, 2025
10
SEC EDGARForm 4 filed Oct 21, 2024
11
SEC EDGARForm 4 filed Oct 18, 2024
12
SEC EDGARForm 4 filed Nov 16, 2023